| Particulars |
| Company Name |
Suven Pharmaceuticals Ltd |
| Face Value |
1 |
| BSE Code |
543064 |
| Year End |
202403 |
| Full Year |
| Equity (Rs . Cr) |
25.46 |
| B.V. (Rs) |
86.70 |
| Sales (Rs . Cr) |
1,024.99 |
| NP (Rs . Cr) |
272.29 |
| NP Var% |
-35.00 |
| Div% |
0.00 |
| CPS (Rs) |
12.60 |
| EPS (Rs) |
10.70 |
| Traded Value(Rs . Lakhs) |
36.37 |
| 52 Week High |
1,359.00 |
| 52 Week Low |
597.00 |
| Price BSE |
1,083.00 |
| Price NSE |
1,082.00 |
| Market Capital(Rs . Cr) |
27,578.29 |
| P/C Ratio |
85.90 |
| P/E Ratio |
101.30 |
| Price Vs.BV |
12.49 |
| Latest Quarter |
| Year End |
202412 |
| Sales (Rs . Cr) |
275.39 |
| NP (Rs . Cr) |
86.35 |
| NP Var % |
65.00 |
| Trailing Twelve Months |
| Year End |
202412 |
| Sales |
914.50 |
| OPM |
35.57 |
| NP |
247.20 |
| NP Var% |
-26.30 |
| EPS |
11.05 |
| PE |
98.04 |
|